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RESUMEN
Tripeptide-9-citrulline (nombre INCI) es un péptido para 
el cuidado de la piel, usado en aplicaciones cosméticas. 
Para elucidar su mecanismo de acción en aquellas vías 
químicas que implican iones metálicos, se ha estudiado 
su capacidad para formar complejos metálicos. Dicho es-
tudio se ha llevado a cabo utilizando técnicas espectrofo-
tométricas, electroquímicas y electroforéticas. Los resul-
tados obtenidos, usando Cu (II) como ión metálico, son 
consistentes con la formación de un complejo entre Tri-
peptide-9-citrulline y el ion metálico. La voltametría cícli-
ca ha revelado un cambio significativo en los potenciales 
electroquímicos. Finalmente se ha demostrado mediante 
experimentos de electroforéticos que Tripeptide-9-citrulli-
ne podría proteger el ADN de la degradación inducida por 
los radicales producidos en la reacción de Fenton.
Palabras clave: Voltametría cíclica, DNA, Reacción de 
Fenton, Péptido
SUMMARY
Tripeptide-9 Citrulline (INCI name) is a peptide with skin 
care properties, used for cosmetic applications. In order 
to elucidate its mechanism of action in the chemical path-
ways that involve metal ions, its ability to complex such 
ions was investigated using spectrophotometrical, electro-
chemical and electrophoretical techniques. The obtained 
results using Cu(II) as metal ion were consistent with the 
formation of a complex between Tripeptide-9 Citrulline and 
Cu(II). Cyclic voltammetry revealed a significant change 
in the electrochemical potentials. In-vitro electrophoretic 
studies served as a proof of concept that Tripeptide-9 Ci-
trulline may protect DNA from radical degradation induced 
by the Fenton reaction.
Keywords: Cyclic voltammetry, DNA, Fenton reaction, 
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RESUM
Tripeptide-9-citrulline (Nom INCI) és un pèptid usat en 
aplicacions cosmètiques que tenen cura de la pell. Per a 
elucidar el seu mecanisme d’acció en aquelles vies quími-
ques que involucren ions metàl·lics, s‘ha estudiat la seva 
capacitat per a format complexos metàl·lics. Aquest es-
tudi s’ha dut a terme utilizant tècniques espectrofotomè-
triques, electroquímiques i electroforètiques. Els resultats 
obtinguts, emprant (II) com a ió metàl·lic, són consistents 
amb la formació d’un complex entre Tripeptide-9-citru-
lline i el ió metàl·lic. La voltametria cíclica revela un canvi 
significatiu entre els potencials electroquímics. Finalment, 
s’ha demostrat mitjançant experiments electroforètics que 
Tripeptide-9-citrulline podria protegir l’ADN de la degrada-
ció induïda pels radicals produïts en la reacció de Fenton.
Paraules clau: Voltametria cíclica, ADN, Reacció de Fen-
ton, Pèptid
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INTRODUCTION
Skin is considered to be the largest organ in the human 
body weighing about 3 Kg spread over an area of roughly 
1.5 m2. Similar to other cells in the human body, skin cells 
breathe and consume energy and spontaneously gener-
ate reactive oxygen species (ROS)1 which can be toxic 
and often cause cell damage due to various mechanisms 
mainly oxidation of membrane phospholipids, proteins, 
and nucleic acids.2 Two groups of ROS species have been 
identified, radicals and non-radicals. The radicals group 
includes superoxides (O2
•Θ), hydroxys (HO•), alkoxys (RO•), 
hydroperoxides (HO2
•) and peroxys (RO2
•),3 whereas sin-
glet oxygen (1O2), hydrogen peroxide H2O2, ozone (O3), 
hypochlorous acid (HOCl) and peroxynitrite (ONOOΘ) rep-
resent the non-radicals. Among these species, H2O2 has 
special biological relevance due to its ability to interact 
with redox-active transition metals such as Cu(II), yield-
ing other ROS products such as the hydroxy radical HO•,4 
commonly known as the most oxidative reactant as well 
as most damaging among all known ROS species,5-6. As 
depicted in Scheme I, H2O2 can react with transition metal 
ions to yield ROS via the Fenton reaction. in addition, H2O2 
is freely diffusible into cells and can potentially reach the 
DNA in the nucleus.[7] DNA molecules, on the other hand, 
can also bind to metal cations at two binding sites: the an-
ionic phosphate groups and the electron donor atoms on 
the heterocyclic bases8 yielding structures such as those 
shown in Figure 1.  
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Figure 1. Cu(II)-DNA coordination. Adapted from8
To better appreciate the severity of this process, one must 
keep in mind the large amount of oxygen which enters 
the cells (1012 molecules /cell/day). Reactions of organic 
molecules (e.g. sugars) with molecular oxygen to gener-
ate reactive oxygen radicals do not occur because most 
organic molecules exist in the spin state whereas O2 exists 
in the triplet spin state (reactions of a triplet with a singlet 
molecule are very unlikely as evidenced in their slow rate 
(10-5M-1s-1)).4 However, transition metals like iron or copper 
can bridge this kinetic restriction by reducing O2 to form 
radical species that are capable of reacting with organic 
molecules.
With these considerations in mind, this investigation aims 
at studying the chelating properties of different com-
pounds and their ability to reduce or eliminate interactions 
between ROS species, namely O2 and H2O2 with metal 
ions to eliminate their oxidative stress and other harmful 
chemical reactions on biomolecules (such as DNA and 
proteins,. In this paper we report on the chelating ability 
of transition metals by Tripeptide-9 Citrulline using various 
techniques such as spectrophotometry, electrochemistry 
and electrophoresis. Cu(II) has been used routinely as a 
model cation due to its role as one of the most important 
transition metal ions in biological systems.9
MATERIALS AND METHODS
Materials
Tripeptide-9 Citrulline (CAS nr. 951775-32-9) was supplied 
by Lipotec S.A. Plasmid pBR322 as well as all other 
analytical grade chemicals were obtained commercially.
Methods 
UV-VIS Spectrophotometry: Tripeptide-9 Citrulline and 
CuSO4 solutions were mixed at different ratios and diluted 
to predetermined concentrations in a pH 5.5 acetate buffer 
with constant mechanical mixing. Absorbance spectra of 
peptide/Cu(II) mixtures were recorded with a UV-VIS Spec-
trophometer Shimadzu UV-1700 Series. The same acetate 
buffer was used for baseline readings.
Electrochemical studies: The electrochemical experiments 
were performed using a Metrohm 757 VA Computrace us-
ing a platinum wire as a working electrode, a platinum rod 
counter electrode and Ag/AgCl/KCl (3 M) reference elec-
trode. All samples were placed in 10-ml conventional glass 
cells. Prior to electrolysis, the platinum working electrode 
was cleaned by heating the electrode using a Bunsen 
burner until incandescence. The experimental conditions 
of the cyclic voltammograms were: Mode DC, Equilibra-
tion time 5 s, Initial potential 1.25 V, Inversion potential 
-0.95V and sweep rate 100 mV/s. All cyclic voltammetry 
experiments were obtained beginning with a cathodic 
sweep. Electrolytes used in this experiment were aqueous 
solutions of 1 M Na2SO4 which have been degassed by N2 
bubbling for 5 min prior to the experiments.
Electrophoresis: Aliquots of plasmid DNA pBR322 (0.70 
mg/mL) were incubated in TE buffer (10 mM Tris.HCl, 1 
mM EDTA, pH = 7.5) at molar ratios ri = 0.02 and 0.005 for 
electrophoresis experiments. Incubation of the samples 
was carried out at 37°C for 5 minutes in the absence of 
light. 1 μL marker was added to different aliquots (20 μL) 
of compound-DNA complex and free DNA was used as 
a control. Agarose gel electrophoresis (1% in TBE buffer, 
Tris-borate-EDTA) was run for 5 hours at 75 V/cm followed 
by staining in an ethidium bromide solution (0.75 mg / ml 
in TBE) for 6 hours. The experiment was carried out in a 
horizontal Ecogen tank connected to a Pharmacia GPS 
200/400 with a variable power supply potential. The gel 
was photographed using a camera Image Master VDS 
(Pharmacia Biotech).
RESULTS AND DISCUSSION
Spectrophomometric studies of metal chelating pro-
perties of Tripeptide-9 Citrulline
In order to investigate the chelation of Cu(II) by Tripepti-
de-9 Citrulline, mixtures of these two components at di-
fferent ratios were prepared with the Tripeptide-9 Citrulline 
used as a control. Mere visual inspection of the samples 
revealed that the intensity of the blue colour qualitatively 
increased with increased concentration of the Tripeptide-9 
Citrulline (data not shown). UV-VIS absorbance scan spec-
tra showed a maximum Cu(II) wavelength absorbance at 
816 nm (Figure 2). Addition of the Tripeptide-9 Citrulline to 
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Cu(II) showed the emergence of a very intense new maxi-
mum peak at 635 nm, consistent with visual observations. 
Maximum absorbance peak shift for all concentrations of 
the Tripeptide-9 Citrulline used in this study are shown in 
Table 1.
*Peptide = Tripeptide-9 Citrulline; ** = Concentration is 
expressed in mM
Figure 2. UV-VIS Spectrophotometry spectra of mixtures 
of Cu (II) with Tripeptide-9 Citrulline at different ratios. For 
experimental conditions, refer to “Materials and Meth-
ods” section. Absorbance units are adimensional.
Table 1. Absorbance values of solutions con-
taining Tripeptide-9 Citrulline and CuSO4. 
[Tripeptide-9 
Citrulline] (mM)
[CuSO4] 
(mM)
Wavelenght of 
maximum ab-
sorbance (nm)
Absorbance 
at 635 nm
0 12 816 0.034
3 12 659 0.095
6 12 644 0.175
9 12 638 0.230
12 12 636 0.289
15 12 635 0.351
18 12 635 0.404
18 0 No absorption No absorption
Taking into account that Tripeptide-9 Citrulline does not 
show any absorption in the UV-VIS range studied, and 
as the quantity of Cu(II) is constant in all the samples, in 
the absence of interaction between the two compounds 
the same UV-VIS spectrum corresponding to Cu(II) would 
be expected. On the contrary, the experimental behavior 
is consistent with the formation of a complex formed by 
Cu(II) and Tripeptide-9 Citrulline, and its intensity at diffe-
rent Cu(II) concentrations is reflected in the maximum peak 
absorbance at 635 nm (Table 1) as shown in Figure 3. A 
simple molecular modeling of the Tripeptide-9 Citrulline-
metal complex (Figure 4) was calculated by Chem3D Ultra 
10.0 with metal ion Cu(II) in solution. This model appears 
to indicate that interaction of the Trpeptide-9-Citrulline 
with the metal ion takes place at the amino group moie-
ties. The structure shown in Figure 4 postulates a 1:1 mo-
lar ratio of Cu(II) and Tripeptide-9 Citrulline, however with 
this limited data, it is not possible to propose an accurate 
stoichiometry for the complex between the tripeptide and 
the copper ions.
Figure 3. A635 values corresponding to the spectra of Figure 
2, listed in Table 1. Absorbance units are adimensional.
s
Figure 4. 3D structure of Tripeptide-9 Citrulline-
Cu(II) 1:1 calculated by Chem3D Ultra 10.0
As observed in Figure 3, the values of absorbance at 635 
nm at increasing concentrations of Tripeptide-9 Citrulline 
show no saturation (at the observed range a linear relation-
ship is obtained), even at 1:1 or higher molar ratios. This 
does not necessarily mean that the ratio in the complex is 
higher (e.g. 1 mol Cu(II): 2 mol Tripeptide-9 Citrulline), but it 
could easily be that the equilibrium constant is low. In such 
a case, saturation would never be achieved at the expe-
rimental values of the peptide /Cu(II) ratios. subsequently, 
despite the clear evidence of interaction, determination of 
the stoichiometry of the complex would require further ex-
periments that we consider out of the scope of this work.
This equilibrium is also confirmed by the presence of an 
isosbestic point at ca. 820 nm. Isosbestic points10 are 
commonly found when electronic spectra are recorded (a) 
for a solution in which a chemical reaction or interaction is 
in progress, or (b) for a solution in which the two absorbing 
components and their relative proportions are controlled 
by the concentration of some other component. In our 
experiments, the absorbance spectra of the mixtures of 
Tripeptide-9 Citrulline with Cu(II) have been carried out af-
ter sufficient interaction time in order to reach equilibrium, 
so we consider only possibility “(b)”. According to that, an 
equilibrium between Cu(II), Tripeptide-9 Citrulline and the 
complex (or complexes) Cu(II) / Tripeptide-9 Citrulline is 
postulated, thus concluding that, whatever are the struc-
ture and molarity of the complex, Tripeptide-9 Citrulline is 
able to complex transition metal ions such as Cu(II).
Electrochemical studies of metal chelating properties 
of Tripeptide-9 Citrulline
Cyclic voltammetry is the most versatile electroanalytical 
technique for studying electroactive species.11 Therefore 
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electrochemical measurements of the Tripeptide-9 Citru-
lline–Metal ion interactions is expected to complement 
other methods and to yield information on the mechanism 
of interaction as well as conformation of the adduct.12
Similar to earlier studies using cyclic voltammetry for in-
vestigating the ability of organic molecules to complex 
ions13-16 we have performed electrochemical analysis of 
mixtures of Tripeptide-9 Citrulline and Cu(II). Figure 5A 
shows the cyclic voltammogram of 1 M Na2SO4 solution 
(blank). Two more peaks can be observed in the cathodic 
sweep, presumably due to the hydrogen adsorption on the 
platinum surface.17 It is important to note that the potential 
window of the electrolyte used (1 M Na2SO4) is limited by 
oxygen evolution on the anodic region (E>1.2 V vs. Ag/
AgCl/KCl (3 M)) and by hydrogen evolution on the cathodic 
region (E<-0.9 V vs. Ag/AgCl/KCl (3 M)). Figure 5B shows 
the cyclic voltammogram of 1 mM Tripeptide-9 Citrulline in 
1 M Na2SO4 solution with two small peaks in the cathodic 
sweep due to the hydrogen adsorption on the platinum 
surface. In addition a small bump appears in the anodic 
sweep at -734 mV which could be due to oxidation of the 
Tripeptide-9 Citrulline. Figure 5C shows the cyclic voltam-
mogram of 1 mM CuSO4/1 M Na2SO4 solution (working 
solution) and corresponding peak potentials are listed in 
Table 2. In this same Figure, new peaks appear both in the 
cathodic and anodic sweep compared to the blank solu-
tion (see Figure 5A) with those of the cathodic sweep may 
be interpreted as due to reduction reactions of copper ions 
in the working electrode. In the anodic sweep, three peaks 
were observed (see Table 2) with two of these peaks likely 
corresponding to oxidation reactions complementary to 
the reduction processes mentioned above. The third peak 
may be attributed to an adsorption/desorption process of 
the copper ion at the electrode surface.
Figure 5. Cyclic voltammograms of Tripeptide-9 Citrul-
line / CuSO4 solutions at different concentrations in 1 M 
Na2SO4 (working solution). 5A, Na2SO4 solution (blank); 
5B, 1 mM Tripeptide-9 Citrulline; 5C, 1 mM CuSO4; 5D, 
1 mM Tripeptide-9 Citrulline + 1 mM CuSO4; 5E, 2 mM 
Tripeptide-9 Citrulline + 1 mM CuSO4; 5F, 20 mM Tri-
peptide-9 Citrulline + 20 mM CuSO4. For experimental 
conditions, refer to “Materials and Methods” section.
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Table 2. Peak potentials (Ep) of the cyclic voltammograms 
of Tripeptide-9 Citrulline at different concentrations in 1 mM 
CuSO4 and 1 M Na2SO4 solution (working solution). “c” and 
“a” indicate cathodic and anodic sweep, respectively).
[Tripeptide-9 
Citrulline] (mM) Epa (mV) Epc (mV) Voltammogram
0 Epa(1): -357Epa (2): -186
Epc(1): -67
Epc(2): +60
Epc(3): +266
Figure 5C
1 Epa(1): -777Epa(2): -55
Epc(1): -305
Epc(2): -15
Epc(3): +357
Figure 5D
2 Epa(1): -777Epa(2): -15
Epc(1): -313
Epc(2): -12
Epc(3): +421
Figure 5E
20 Epa(1): -742Epa(2): +12
Epc(1): -456
Epc(2): +464 Figure 5F
Figure 5D shows the cyclic voltammogram of 1 mM Tri-
peptide-9 Citrulline + 1 mM CuSO4/1 M Na2SO4 solution 
with Table 2 listing the corresponding peak potentials. Two 
reduction peaks in the cathodic sweep and three oxida-
tion peaks in the anodic sweep were observed. Compa-
red to cyclcic voltammetry data of the 1 mM CuSO4/1 M 
Na2SO4 solution (Figure 5C), a potential shift in peaks is 
evident in Figure 5.D. Epc(2) in 1 mM CuSO4/1 M Na2SO4 
was -186mV (Table 2) and when 1 mM Tripeptide-9 Citrulli-
ne was added to the working solution, the peak shifted to 
-55mV. In addition, the corresponding anodic peak shifted 
too: Epa(2) in 1 mM CuSO4/1 M Na2SO4 was -67 mV and 
when 1mM Tripeptide-9 Citrulline was added the peak shi-
fted to -15 mV.
The change in the peak potentials of the cyclic voltammo-
grams when Tripeptide-9 Citrulline was added to the cop-
per solution reveals that there is an interaction between 
the Tripeptide-9 Citrulline and the copper ions. It seems 
that when Tripeptide-9 Citrulline was added, the electro-
chemical processes of the copper reduction/oxidation be-
came more reversible. Figure 5E shows the cyclic voltam-
mogram of 2 mM Tripeptide-9 Citrulline + 1 mM CuSO4/1 
M Na2SO4 solution and the corresponding peak potentials 
are listed in Table 2.
It should be noted that when the concentration of the 
Tripeptide-9 Citrulline was increased to 2 mM the peak 
potentials changed again (Table 2). The main difference 
observed when the concentration of Tripeptide-9 Citrulli-
ne was increased was the change in Epc(2) and Epa(2). 
Note that both peak potentials, Epc(2) and Epa(2), evol-
ved to more anodic potentials when the concentration of 
Tripeptide-9 Citrulline was increased. In addition, the gap 
between both potentials decreased as a function of the 
Tripeptide-9 Citrulline concentration. Again, it seems that 
the electrochemical reversibility of the copper reduction/
oxidation processes increased as a function of the Tripep-
tide-9 Citrulline concentration. Figure 5F shows the cyclic 
voltammogram of 20 mM Tripeptide-9 Citrulline + 1 mM 
CuSO4/1 M Na2SO4 solution and the corresponding peak 
potentials are listed in  Table 2.
DNA protection by metal chelating ability of Tripepti-
de-9 Citrulline
The damage to DNA produced by Fe(II)-mediated Fenton 
reactions, with sequence-specific cleavage, has been re-
ported.18 Moreover, exposure to Fenton reagents leads 
to the formation of in-strand cross-link lesions where the 
neighboring nucleobases in the same DNA strand are co-
valently bonded.19
The spectrophotometric and electrochemical investiga-
tions described above give information about the comple-
xation of metal transition ions by Tripeptide-9 Citrulline; in 
order to study the protective effect of this chelating ability 
of DNA against stress conditions of the Fenton reaction 
(Scheme 1), a proof of the concept of tertiary-structured 
DNA protection was designed. This proof was provided by 
electrophoresis experiments using commercially available 
plasmid pBR322. The electrophoretic pattern of pBR322 
(Figure 6, Lane 3) shows two bands with different mobi-
lities corresponding to covalently closed (CCC) and open 
form (OC). pBR322 was incubated in the Fenton reaction 
conditions with Cu(II) and H2O2 (see Materials and Methods 
for details) in the absence (Figure 6, Lane 1) or the pre-
sence (Figure 6, Lane 2) of the Tripeptide-9 Citrulline. In 
the absence of the  Tripeptide-9 Citrulline H2O2 (Figure 6, 
Lane 1), the bands CC and OC bands are no longer obser-
ved, and a single diffuse band was observed instead. This 
is attributed to the Fenton reaction that has taken place, 
resulting in the emergence of various free radicals such 
as hydroxyl radicals, which ultimately have degraded the 
plasmid. However, results of the experiment performed in 
the  presence of Tripeptide-9 Citrulline are completely di-
fferent: when Tripeptide-9 Citrulline is present at the begin-
ning of the incubation with the Fenton reagents, the elec-
trophoretic profile (Figure 6, Lane 2) is similar to the one of 
untreated plasmid (figure 6, Lane 3), indicating that DNA 
remains virtually unchanged.
Lane 1 Lane 2 Lane 3 DNA form
Figure 6. Effect of the Fenton reaction in the electropho-
retic mobility of DNA pBR322 plasmid. For experimen-
tal details, refer to “Materials and Methods” section.
OC
CCC
AfinidAd LXiX, 560, Octubre - Diciembre 2012250
This constitutes a proof of the ability of Tripeptide-9 Citru-
lline to complex metal ions present in solution, preventing 
them from reacting with the hydrogen peroxide present in 
the medium and the subsequent inhibition of free radicals 
formation, thus offering an effective protection of DNA 
against Fenton degradation reaction.
Scheme 1. Reaction of metal species with H2O2 
generating ROS, adapted from literature 8,9.
Men⊕ + H2O2 → Me
(n-1)⊕ + O2
•Θ + 2H⊕ adapted from8 
Me(n-1)⊕ + H2O2 → MeOOH
⊕ + H⊕  adapted from8 
Me(n-1)⊕ + H2O2 → Me
n⊕ + HO• + OHΘ adapted from9
CONCLUSIONS
UV-VIS Spectrophotometry and cyclic voltammetry have 
shown to be valuable tools for demonstrating the ability 
of a peptide to chelate transition metal ions. The presen-
ce of isosbestic point in UV-VIS spectra at different ratios 
of peptide/metal and the change in the peak potentials 
of the cyclic voltammograms when Tripeptide-9 Citrulline 
was added to the copper solution are two independent 
confirmations of the presence of interaction between the 
Tripeptide-9 Citrulline and Cu(II) ions in aqueous solution. 
Interactions of Tripeptide-9 Citrulline with other transition 
metals of similar electronic configuration such as Fe(II) are 
expected. Furthermore, the ability of Tripeptide-9 Citrulli-
ne to complex metal transition ions provides protection of 
biomolecules from Fenton degradation reaction involving 
the formation of several ROS. Electrochemical reversibility 
of the copper ions reduction/oxidation processes increa-
sed with the Tripeptide-9 Citrulline concentration. Accor-
ding to this interaction, the introduction of this peptide 
in cosmetic preparations can provide protection against 
cellular damage by different reactive species formed bet-
ween metal ions and biological molecules.
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